Prosecution Insights
Last updated: November 20, 2026

Trent R Clarke, USPTO Patent Examiner

Listed by the USPTO as CLARKE, TRENT R

Tech Center 1600 • Art Units: 1651 1657 1678

This examiner grants 42% of resolved cases

Analysis

CLARKE, TRENT R is a USPTO patent examiner in Tech Center 1600 and Art Unit 1651. The profile covers 443 resolved cases, a 42.2% allowance rate, and a 24.6% interview lift. The median time to allowance is 1382 days. The record indicates a moderate allowance outcome and a meaningful positive association between interviews and prosecution results.

The leading companies are Revival Animal Health LLC, Restem LLC, and The Regents of the University of Michigan. The leading firms are The Juhasz Law Firm, P.C., AMSTER, ROTHSTEIN & EBENSTEIN LLP, and CANTOR COLBURN LLP. Practitioners should plan for extended prosecution, use interviews to clarify disputed issues, and support those discussions with carefully targeted claim amendments and evidence.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

42.2%
Allow Rate
-17.8% vs TC avg
485
Total Applications
+24.6%
Interview Lift
1382
Avg Prosecution Days
Based on 443 resolved cases, 2023–2026

Rejection Statute Breakdown

5.1%
§101 Eligibility
11.6%
§102 Novelty
42.7%
§103 Obviousness
27.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17923679 FUNCTIONALIZED POLY(GLYCEROL SEBACATE)S AND USES THEREOF Final Rejection CORNELL UNIVERSITY
18190660 Using Water Ponds for Capturing Dioxide and Growing Algae Non-Final OA Saudi Arabian Oil Company
18684262 METHODS COMPRISING THERAPEUTIC COMPOUNDS AND IN VITRO MAMMALIAN SKIN Non-Final OA AMGEN INC.
18889325 Methods and Compositions for Preserving Tissues and Organs Non-Final OA The General Hospital Corporation
18003570 CONTROLLING OPERATION OF A BIOREACTOR VESSEL Non-Final OA IPSEN BIOPHARM LIMITED
18814678 ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS) Non-Final OA The University Court of the University of Glasgow
18739573 CELL SAMPLE EVALUATION METHOD, CELL SAMPLE EVALUATION APPARATUS, AND CULTURE STATE ANALYSIS APPARATUS Non-Final OA HAMAMATSU PHOTONICS K.K.
17425039 MICROCARRIER FOR CELL CULTURE, METHOD FOR PRODUCING THE SAME, AND CELL CULTURE METHOD USING THE SAME Non-Final OA LG CHEM, LTD.
19030781 BALANCED SYSTEM AND METHOD FOR PRODUCTION OF MICROBIAL OUTPUT Non-Final OA Tenfold Technologies, LLC
18704742 RECOMBINANT YEAST CELL Final Rejection DANISCO US INC.
18719120 A METHOD FOR SEPARATING SUPERCOILED PLASMID DNA Non-Final OA Cytiva BioProcess R&D AB

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Trent R Clarke's allowance rate?

42.2% of resolved applications examined by Trent R Clarke were allowed (443 resolved cases), compared with 31.5% across Art Unit 1651 over the last five years.

Does an interview help with examiner Trent R Clarke?

This examiner's interview lift is +24.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Trent R Clarke take to allow a patent?

Applications allowed by Trent R Clarke took 1,382 days on average from filing to allowance.

Which art unit does examiner Trent R Clarke work in?

Trent R Clarke examines applications in Art Unit 1651 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month